Cargando…
Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
Although the association between acute exacerbation of interstitial lung disease and vaccination is not yet clarified, this is the first case report describing the possibility that SARS-CoV-2 vaccination may trigger acute exacerbation https://bit.ly/3tpu6Cz
Autores principales: | Bando, Tomohiro, Takei, Reoto, Mutoh, Yoshikazu, Sasano, Hajime, Yamano, Yasuhiko, Yokoyama, Toshiki, Matsuda, Toshiaki, Kataoka, Kensuke, Kimura, Tomoki, Kondoh, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832376/ https://www.ncbi.nlm.nih.gov/pubmed/35144990 http://dx.doi.org/10.1183/13993003.02806-2021 |
Ejemplares similares
-
Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia
por: Bando, Tomohiro, et al.
Publicado: (2022) -
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023) -
Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
por: Ishihara, Hiroyuki, et al.
Publicado: (2021) -
Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema
por: Suzuki, Atsushi, et al.
Publicado: (2018) -
Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system
por: Mutoh, Yoshikazu, et al.
Publicado: (2022)